Development of a newly immunoassay specific for mouse presepsin (sCD14-ST)

Presepsin (sCD14-ST) is used as a marker for sepsis diagnosis. The production mechanism of presepsin is unique in that it is produced through phagocytosis of microorganisms. However, some studies have demonstrated that non-infected patients had increased presepsin levels and that presepsin is related to the risk or severity of diseases. This study was designed to describe a sensitive sandwich enzyme-linked immunosorbent assay for mouse presepsin developed to investigate the association of presepsin with diseases. Polyclonal antibodies were generated from peptide-immunized rabbit antiserum. Mouse presepsin standard was prepared using the recombinant method as an Fc-fusion protein. The linear detection range of the method was 4.7–300 pg/mL with a detection limit of 1.4 pg/mL. The assay detected mouse presepsin where mouse soluble CD14 (sCD14) was digested by cathepsin D proteinase and the cross-reactivity of sCD14 was not observed. The normal levels of mouse presepsin and sCD14 were compared; 65.9 ± 21.4 pg/mL and 43.2 ± 7.2 ng/mL were determined, respectively. Moreover, the levels of presepsin and sCD14 were compared with a lipopolysaccharide (LPS)-injected sepsis mouse model. The newly developed analytical method had high specificity to presepsin and is an efficient tool for studying the association between presepsin and diseases.

• Publication year

  2022

• Venue

  Scientific Reports

• Publication date

  2022-12-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/s41598-022-22096-1PMID 36522357PMCID 9755121
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Presepsin in risk stratification of SARS-CoV-2 patients

  2020cited by this paper
• Presepsin values as markers of severity of sepsis.

  2020cited by this paper
• A Novel Tau Antibody Detecting the First Amino-Terminal Insert Reveals Conformational Differences Among Tau Isoforms

  2020cited by this paper
• An evolutionary perspective

  2019cited by this paper
• Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach.

  2018cited by this paper
• Clinical significance of plasma presepsin levels in patients with systemic lupus erythematosus

  2018cited by this paper
• Mouse models of lupus: what they tell us and what they don’t

  2018cited by this paper
• Increased presepsin levels are associated with the severity of fungal bloodstream infections

  2018cited by this paper
• CD14 Plays a Protective Role in Experimental Inflammatory Bowel Disease by Enhancing Intestinal Barrier Function.

  2017cited by this paper
• Mouse models of human disease

  2016cited by this paper
• Current Murine Models of Sepsis

  2016cited by this paper
• Presepsin (sCD14-ST) secretion and kinetics by peripheral blood mononuclear cells and monocytic THP-1 cell line.

  2016cited by this paper
• Phagocytosis by human monocytes is required for the secretion of presepsin.

  2015cited by this paper
• Mouse models of human disease

  2012cited by this paper
• Usefulness of presepsin (Soluble CD14 subtype) as a diagnostic marker of sepsis

  2012cited by this paper
• Presepsin (sCD14-ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in septic patients

  2011cited by this paper
• Lipopolysaccharide inhibits macrophage phagocytosis of apoptotic neutrophils by regulating the production of tumour necrosis factor α and growth arrest‐specific gene 6

  2011cited by this paper
• Detection of chymase-digested C-terminally truncated apolipoprotein A-I in normal human serum.

  2011cited by this paper
• Development of a point-of-care assay system for measurement of presepsin (sCD14-ST).

  2011cited by this paper
• Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis

  2005cited by this paper
• Alterations in membrane-associated CD14 expression and the simultaneous liberation of soluble CD14 fragment in adherent macrophages mediated by a leukocyte carboxyl/aspartate protease

  2002cited by this paper
• Identification of a Domain in Soluble CD14 Essential for Lipopolysaccharide (LPS) Signaling but Not LPS Binding (*)

  1995cited by this paper
• Soluble CD14 Truncated at Amino Acid 152 Binds Lipopolysaccharide (LPS) and Enables Cellular Response to LPS (*)

  1995cited by this paper

• Narrative Review: Research Progress and Future Directions of Presepsin in Neurological Prognostication of Adult Post-Return of Spontaneous Circulation (Post-ROSC) Cardiac Arrest Survivors

  2026cites this paper
• Tenascin-C, presepsin (sCD14-ST), and neutrophil-to-lymphocyte ratio as complementary circulating biomarkers for sepsis-associated organ dysfunction and 28-day all-cause mortality: a biomarker-enriched prognostic model

  2026cites this paper
• Identification of organs of origin of macrophages that produce presepsin via neutrophil extracellular trap phagocytosis

  2024cites this paper